Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FAZLB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,449
Award facts
- Contract value 100% obligated
- $49,449.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $49,449.30 by the Defense Logistics Agency (DLA) on September 24, 2025. The contract calls for the delivery of Entyvio 300 mg vials, a pharmaceutical product used in the treatment of inflammatory bowel disease. This firm fixed-price delivery order is scheduled for ultimate completion on October 16, 2025, with performance taking place at the contractor's facility in Park Ridge, Illinois. The award was made without any small business set-aside designation.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to consistently secure contracts for branded and generic prescription drugs, biologics, and specialty medications supporting military health operations.
Quick answers
Who was awarded contract SPE2DB25FAZLB?
SPE2DB25FAZLB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FAZLB worth?
The government has obligated $49,449 on SPE2DB25FAZLB.
Is contract SPE2DB25FAZLB an order under another contract?
Yes. SPE2DB25FAZLB is a delivery order under SPE2DB24D9222, an indefinite delivery contract.
Was contract SPE2DB25FAZLB competed?
The extent of competition for SPE2DB25FAZLB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award